GABARAP and breast carcinoma: Similarly, a peptide mimicking the γ-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) which interacts with TRPV1 [107] has been proposed as a good candidate to promote TRPV1-associated suppression of breast cancer progression [108].